Mobile

A Phase III, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellit...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020234-26

A Phase III, Multicenter, Double-Blind, Randomized, Active-Controlled Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

After 30 weeks, in elderly patients with T2DM with inadequate glycemic control on diet and exercise: 1) To assess the effect of sitagliptin compared with glimepiride on A1C. 2) To assess the effect of sitagliptin compared with glimepiride on the incidence of adverse events of symptomatic hypoglycemia

Critère d'inclusion

  • Type 2 diabetes mellitus

Liens